Диссертация (1155054), страница 30
Текст из файла (страница 30)
Кулапина, В.Ф. Киричук, И.А. Утц [и др.] // Серия Критическиетехнологии,Мембраны. – 2005. – Т. 1. – № 25. – с. 3-11.14. Райков А.О. Липосомы для направленной доставки противоопухолевыхпрепаратов / А.О. Райков, А. Хашем, М.А. Барышникова // Российскийбиотерапевтический журнал. – 2008. – Т. 15. – № 15. – с. 90-96.15.
Способ определения размера клеток: SU1337349 A1 СССР: МПК: G 01 N33/48 / Б.И. Шварцбург; институт биохимии и физиологии растений имикроорганизмов ан ссср, саратовский государственный университет им. н. г.чернышевского - № 3748690; зявл. 01.06.1984 ; опубл. 15.09.1987 бюл. № 34. – 4с.16. Установление оптимальных условий для стандартизации винбластинаметодомспектрофотометрии / А.Д. Халахакун, П.М. Карлов, А.И.
Сливкин [идр.] // VI Международная научно-методическая конференция «пути и формысовершенствованияфармацевтическогообразования.созданиеновыхфизиологически активных веществ». – 2016. – c. 573-575.17. Установление оптимальных условий для стандартизации винкристинаметодом спектрофотометрии / А.Д. Халахакун, П.М. Карлов, А.И. Сливкин [идр.] // VI Международная научно-методическая конференция «пути и формысовершенствованияфармацевтическогообразования.созданиеновыхфизиологически активных веществ». – 2016. – c.
570-572.18618. Халахакун А.Д., Сливкин А.И., Карлов П.М. Возможности примененияспектрофотометрического метода для стандартизации алкалоидных препаратоввинкристина и винбластина в субстанциях, и лекарственных формах / ХалахакуА.Д., Сливкин А.И., Карлов П.М. // Успехи современной науки. – 2017. – Vol. 6.– № 1. – с. 34-45.19. A 20% dose reduction of the original CISCA/VB regimen allows better toleranceand similar survival rate in disseminated testicular non-seminomatous germ-celltumors: final results of a phase III randomized trial. / K.
Fizazi, K.A. Do, X. Wang [etal.] // Annals of oncology : official journal of the European Society for MedicalOncology. – 2002. – Vol. 13. – № 1. – P. 125-34 doi:10.1093/annonc/mdf005.20. A novel submicron emulsion system loaded with vincristine–oleic acidion-pair complex with improved anticancer effect: in vitro and in vivo studies / T.Zhang, Zheng, Q.
Peng [et al.] // International Journal of Nanomedicine. – 2013. –Vol. 8. – P. 1185 doi:10.2147/IJN.S41775.21. A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decoratedliposome system for protein delivery: An application for bladder cancer treatment / M.Vila-Caballer, G. Codolo, F. Munari [et al.] // Journal of Controlled Release. – 2016. –Vol. 238. – P. 31-42 doi:10.1016/j.jconrel.2016.07.024.22. A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 inpatients with advanced solid tumors. / A.W. Tolcher, J.D.
Berlin, J. Cosaert [et al.] //Cancer chemotherapy and pharmacology. – 2017. – Vol. 79. – № 4. – P. 673-680doi:10.1007/s00280-017-3245-5.23. Acharya S. PLGA nanoparticles containing various anticancer agents and tumourdelivery by EPR effect / S. Acharya, S.K. Sahoo // Advanced Drug Delivery Reviews.– 2011.
– Vol. 63. – № 3. – P. 170-183 doi:10.1016/j.addr.2010.10.008.24. Advances of blood cell-based drug delivery systems / Y. Sun, J. Su, G. Liu [et al.]// European Journal of Pharmaceutical Sciences. – 2017. – Vol. 96. – P. 115-128doi:10.1016/j.ejps.2016.07.021.18725. Akhmanova A. Tracking the ends: a dynamic protein network controls the fate ofmicrotubule tips / A. Akhmanova, M.O. Steinmetz // Nature Reviews Molecular CellBiology.
– 2008. – Vol. 9. – № 4. – P. 309-322 doi:10.1038/nrm2369.26. Aleksandrovna P.Y. Validation of assay procedures of afobazolein microcapsules /P.Y. Aleksandrovna, S.A. Ivanovich, H.A. Jeewantha // International Journal ofPharmacy and Pharmaceutical Sciences. – 2017.
– Vol. 9. – № 5. – P. 278doi:10.22159/ijpps.2017v9i5.16684.27. Almagro L. Indole Alkaloids from Catharanthus roseus: Bioproduction and TheirEffect on Human Health / L. Almagro, F. Fernández-Pérez, M. Pedreño // Molecules. –2015. – Vol. 20. – P. 2973-3000 doi:10.3390/molecules20022973.28. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery./ J.W. Park, K. Hong, D.B. Kirpotin [et al.] // Clinical cancer research : an officialjournal of the American Association for Cancer Research. – 2002.
– Vol. 8. – № 4. –P. 1172-81.29. Antihyperglycemic activity of Catharanthus roseus leaf powder in streptozotocininduced diabetic rats / S. Desireddy, K. Rasineni, R. Bellamkonda [et al.] //Pharmacognosy Research. – 2010. – Vol. 2. – № 3. – P. 195 doi:10.4103/09748490.65523.30. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinatedVinca alkaloid / A.
Kruczynski, J.-M. Barret, C. Etiévant [et al.] // BiochemicalPharmacology. – 1998. – Vol. 55. – № 5. – P. 635-648 doi:10.1016/S00062952(97)00505-4.31. Antitumor Effect of Paclitaxel-Loaded PEGylated Immunoliposomes AgainstHuman Breast Cancer Cells / T. Yang, M.-K. Choi, F.-D. Cui [et al.] // PharmaceuticalResearch. – 2007. – Vol. 24. – № 12. – P. 2402-2411 doi:10.1007/s11095-007-9425-y.32.
Apparent High CYP3A5 Expression Is Required for Significant Metabolism ofVincristine by Human Cryopreserved Hepatocytes / J.B. Dennison, M. a Mohutsky,R.J. Barbuch [et al.] // Journal of Pharmacology and Experimental Therapeutics. –1882008. – Vol.
327. – № 1. – P. 248-257 doi:10.1124/jpet.108.139998.33. Applications of carrier erythrocytes in delivery of biopharmaceuticals / M. Hamidi,A. Zarrin, M. Foroozesh [et al.] // Journal of Controlled Release. – 2007. – Vol. 118. –№ 2. – P. 145-160 doi:10.1016/j.jconrel.2006.06.032.34. Ara N. Comparison of Hypotensive and Hypolipidemic Effects of Catharanthusroseus Leaves Extract with Nifedipine on Adrenaline Induced Hypertensive Rats / N.Ara, M. Rashid, M.S.
Amran // Journal of Biological Sciences. – 2008. – Vol. 8. –№ 6. – P. 1082-1086 doi:10.3923/jbs.2008.1082.1086.35. Avendano C. Anticancer drugs targeting tubulin and Microtubules / C. Avendano,J.C. Menéndez // Medicinal Chemistry of Anticancer Drugs. – Elsevier, 2015. –P. 359-387.36. Aylett C.H.S. New Insights into the Mechanisms of Cytomotive Actin and TubulinFilaments / C.H.S. Aylett, J. Löwe, L.A. Amos // International Review of Cell andMolecular Biology / ed. Kwang W. Jeon.
– Burlington: Elsevier Inc., 2011. – Vol. 292.– P. 1-71 doi:10.1016/B978-0-12-386033-0.00001-3.37. Bacterial ghosts as adjuvant particles / E.M. Riedmann, J.M. Kyd, A.W. Cripps [etal.] // Expert Review of Vaccines. – 2007. – Vol. 6. – № 2. – P. 241-253doi:10.1586/14760584.6.2.241.38. Bae Y.H.
Targeted drug delivery to tumors: Myths, reality and possibility / Y.H.Bae, K. Park // Journal of Controlled Release. – 2011. – Vol. 153. – № 3. – P. 198-205doi:10.1016/j.jconrel.2011.06.001.39. Banerjee N. Nanoerythrosomes - Dawn of A New Era in Carrier MediatedTargeted Drug Delivery / N. Banerjee, S.
Singh // International Journal of Research inPharmaceutical and Biomedical Sciences. – 2013. – Vol. 4. – № 2. – P. 436-455.40. Barik K. Phytochemical and pharmaceutical panorama of Catharanthus roseus / K.Barik, S. Sao, D.K. Parihar // Indo American Pharmaceutical science. – 2016. – Vol. 3.– № 3. – P. 288-293.18941. Baryshnikova M.A. Immunoliposomes and their targets / M.A. Baryshnikova,A.Y. Baryshnikov // Russian Journal of General Chemistry. – 2013. – Vol.
83. – № 12.– P. 2565-2570 doi:10.1134/S1070363213120554.42. Bates D. Microtubule destabilising agents: far more than just antimitotic anticancerdrugs / D. Bates, A. Eastman // British Journal of Clinical Pharmacology. – 2017. –Vol. 83. – № 2. – P. 255-268 doi:10.1111/bcp.13126.43. Bawa R.
FDA and Nano: Baby Steps, Regulatory Uncertainty and the BumpyRoad Ahead / R. Bawa // Handbook of Clinical Nanomedicine Law, Business,Regulation, Safety, and Risk / eds. R. Bawa, G.F. Audette, B.E. Reese. – Boca Raton,FL: CRC Press, 2016. – P. 339-384.44. BC Cancer Agency Cancer Drug Manual:Vinblastine [Электронный ресурс]. –URL:http://www.bccancer.bc.ca/drug-database-site/DrugIndex/Vinblastine_monograph_1Mar08newpolicy.pdf. – (дата обращения:3.3.2017).45. Boman N.L. Optimization of the retention properties of vincristine in liposomalsystems / N.L. Boman, L.D.
Mayer, P.R. Cullis // Biochimica et Biophysica Acta(BBA) - Biomembranes. – 1993. – Vol. 1152. – № 2. – P. 253-258 doi:10.1016/00052736(93)90256-Y.46. Brain uptake and anticancer activities of vincristine and vinblastine are restrictedby their low cerebrovascular permeability and binding to plasma constituents in rat /N.H. Greig, T.T. Soncrant, H.U. Shetty [et al.] // Cancer Chemotherapy andPharmacology. – 1990.
– Vol. 26. – № 4. – P. 263-268 doi:10.1007/BF02897227.47. Brannon-Peppas L. Nanoparticle and targeted systems for cancer therapy / L.Brannon-Peppas, J.O. Blanchette // Advanced Drug Delivery Reviews. – 2004. –Vol. 56. – P. 1649-1659 doi:10.1016/j.addr.2012.09.033.48. Brewer E. Emerging Technologies of Polymeric Nanoparticles in Cancer DrugDelivery / E. Brewer, J. Coleman, A. Lowman // Journal of Nanomaterials. – 2011. –190Vol. 2011. – P. 1-10 doi:10.1155/2011/408675.49. Brittain H.G. Analytical Profiles of Drug Substances and Excipients. Vol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
